Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
Percutaneous revascularisation has evolved dramatically in the past few decades. The approach to the management of ischaemic heart disease has changed due to the development of new devices and techniques as well as the availability of new drugs and treatment strategies. Its use in combination with a...
Saved in:
Main Authors: | Tamara García Camarero, José M de la Torre Hernández |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/ee6142e66f9d4614b35c8e41a8d1ecd8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
by: Despoina-Rafailia Benetou, et al.
Published: (2021) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
by: Despoina-Rafailia Benetou, et al.
Published: (2021) -
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
by: Charalampos Varlamos, et al.
Published: (2021) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
by: Iosif Xenogiannis, et al.
Published: (2021) -
Antithrombotic Therapy after Venous Stent Placement
by: Nicholas Xiao, et al.
Published: (2020)